Introduction The glucagon-like peptide-1 (GLP-1) receptor agonist drug class is widely prescribed to manage type 2 diabetes.1 In large trials of cardiovascular outcomes, GLP-1 receptor agonists were highly effective in achieving glycaemic control, showing beneficial cardiorenal effects and reducing all cause mortality.2 Despite these benefits, recent reports linking GLP-1 receptor agonists to suicidal ideation and self-harm have raised significant concerns.3 The initial signal regarding this possible safety problem emerged from the Icelandic Medicines Agency in July 2023, prompting regulatory bodies worldwide, including the European Medicines Agency and the US Food and Drug Administration, to launch independent investigations into the potential risk of suicidality among GLP-1 receptor agonist users.3 Despite these efforts, regulatory agencies have yet to reach definitive conclusions owing to limitations in the available evidence.45 Clinical trials of GLP-1 receptor agonists have not reported any imbalances in suicidal ideation or self-harm,67 whereas several observational studies have generated varied findings on of the effect of GLP-1 receptor agonists on the risk of suicidal ideation, self-harm, and suicide, which may be a result of methodological limitations in these studies.8910111213 From a biological standpoint, GLP-1 receptor agonists may lead to suicidality through different mechanisms, including hyperactivity of the hypothalamic-pituitary-adrenal axis,14 sudden weight loss leading to elevated suicide risk,1516 and under-expression of brain derived neurotrophic factor linking low body weight and increased anxiety, potentially contributing to higher suicidality.1718 However, the exact manner in which GLP-1 receptor agonists could increase the risk of suicidal ideation and self-harm remains unclear

Oxidative stress throws a wide net in terms of the types of macromolecules and organelles it threatens including proteins, fats, DNA, and even mitochondria
While the largest percentage of intracellular iron is tightly bound to or incorporated into proteins as a cofactor or for storage, small portion of intracellular iron resides in the cytosol and intracellular organelles (e.g., lysosomes) and constitutes a redox-active liable iron pool, which regulates programmed cell death including ferroptosis 42
The Bottom Line for Ozempic Users Ozempic is an important tool for managing diabetes and weight, but it may come with changes in your oral health
A brand that cannot supply a COA for its active ingredient is making an unverifiable claim
La American Diabetes Association (ADA) en sus Estndares de Atencin Mdica en Diabetes y el American College of Physicians (ACP) no incluyen parches transdrmicos en sus guas de prctica clnica, ya que carecen de aprobacin regulatoria y evidencia de eficacia